Essential fatty acids in relation to pregnancy complications and fetal development

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 12, 1998, Pages 1248-1255

  Sattar, Naveed ^a   Berry, Colin ^b   Greer, Ian A ^c  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; FISH OIL; POLYUNSATURATED FATTY ACID; RETINOL;

CLINICAL TRIAL; DIET SUPPLEMENTATION; ESSENTIAL FATTY ACID DEFICIENCY; FETUS DEVELOPMENT; GROWTH; HUMAN; LACTATION; MATERNAL NUTRITION; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; REVIEW;

DIETARY SUPPLEMENTS; EMBRYONIC AND FETAL DEVELOPMENT; FATTY ACIDS, ESSENTIAL; FEMALE; FISH OILS; HUMANS; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; INFANT, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; RISK FACTORS;

EID: 0032422772     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10002.x     Document Type: Review

References (68)

1. Olsen SF, Hansen HS, Sorenson TIA et al. Intake of marine fat. rich in n-3 polyunsaturated fatty acids, may increase birthweight by prolonging gestation. Lancet 1986; 2: 367–369.
2. Dyerberg J, Bang HO. Pre-eclampsia and prostaglandins. Lancet 1985; 1:1267.
3. Romero R, Lockwood C, Oyarzun E. Hobbins, JC. Toxaemia: new concepts in an old disease. Sem Perinatol 1988; 12:302–323.
4. Olsen SF, Olsen J, Frische G. Does fish consumption during pregnancy increase fetal growth? A study of the size of the newborn, placental weight and gestational age in relation to fish consumption during pregnancy. Int J Epidemiol 1990; 19: 971–977.
5. Simopoulos AP. Omega-3 fatty acids in healthy and disease and in growth and development. Am J Clin Nutr 1991; 54: 438–463.
6. Makrides M, Neumann M, Simmer K, Pater J, Gibson R. Are long-chain polyunsaturated fatty acids essential nutrients in infancy Lancet 1995; 345: 1463–1468.
7. Pritchard BNC, Smith CCT, Ling KLE, Betteridge DJ. Fish oils in cardiovascular disease. BMJ 1995; 310: 819–820.
8. Fleischhauer FJ, Yan W-D, Fischell TA. Fish oil improves endothelim-dependent coronary vasodilation in heart transplant recipients. J Am Coll Cardiol 1993; 21:982–989.
9. Pfister SL, Spitzbarth N, Edgemond W, Campbell WB. Vasorelaxation by an endothelium-derived metabolite of arachidonic acid acid. Am J Physiol 1996; 270: H1023–H1030.
10. De Caterina R, Cybulsky MI, Clinton SK. Gimbrone Jr MA, Libby P. The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromh 1994; 14 1829–1836.
11. D’Almeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma Linoleic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992; 19: 117–131.
12. Gerrard J, Popeski D, Ebbelimg L, Brown P, Hornstra G. Dietary omega-3 fatty acids and gestational hypertension in the Inuit. Circumpolar Health 1990: 763–767.
13. Saujurjo P, Matorras R, Ingunza N, Rodiquez-Alarcon J, Pertagudo L. Blue fish intake and percental levels of polyunsaturated plasmatic fatty acids at labor in the mother and the newborn infant. J Perinar Med 1994; 22: 337–344.
14. Olsen SF, Joensen HD. High liveborn birthweights in the Faroes: comparison between birthweights in the Faroes and in Denmark. J Epidemiol Community Health 1985; 39: 27–32.
15. Olsen SF, Sorensen TIA, Secher NJ et al. Randomised controlled trial of effect of fish oil supplementation on pregnancy duration. Lancet 1992; 339: 1003–1007.
16. Olsen SF, Hansen HS, Sommer S, Jensen B, Sorensen TIA, Secher NJ, Zaccharissen P. Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: A study of women in the Faroe Islands and Denmark. Am J Obstet Gynerol 1991; 164: 1203–1209.
17. Olsen SF, Hansen HS, Secher NJ, Jensen B, Sandstrom B. Gestational length and birth weight in relation to intake of marine n-3 fatty acids. Br J Nutr 1995; 73: 397–404.
18. Salvig JD, Olsen SF, Secher NJ. Effects of fish oil in late pregnancy on blood pressure: a randomised trial. Br J Obstet Gynaecol 1996; 103: 529–533.
19. Bulstra-Ramakers MTEW, Huisjes HJ, Visser GHA. The effects of 3 g eicosapentaenioc acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol 1994; 102:123–126.
20. Onwude JL, Lilford Rj, Hjartardottir H, Staines A, Tuffnel D. A randomised double blind placebo controlled trial of fish oil supplementation in high risk pregnancy. Br J Obstet Gynaecol 1994; 102:95–100.
21. Rush D. Evaluation of the special supplemental food program for women, infants and children (WIC). Volume I: summary. Washington, DC: United States Deicosapentaenoic acidrtment of Agriculture, 1986 IV–2.
22. Doyle W, Wynn AHA, Crawford MA, Wynn SW. Nutritional counselling and supplementation in the second and third trimester of pregnancy: a study in the London population. J Nutr Med 1992; 3:249–256.
23. Crawford MA, Doyle W, Leaf A, Leighfield M, Ghebremeskel K, Phylactos A. Nutrition and neurodevelopmental disorders. Nutr Health 1993; 9: 81–97.
24. Beal VA. Nutritional studies during pregnancy. J Am Diet Assoc 1971; 58:1655–1659.
25. MRC Vitamin Study Research group. Prevention of neural tube defects: results of the MRC vitamin study. Lancet 1991; 338:132–137.
26. Secher NJ, Olsen SF. Fish oil and preeclampsia. Br J Obstet Gynaecol 1990; 97: 1077–1079.
27. Broughton-Pipkin F, Crowther C, De Swiet M et al. Where next for prophylaxis against pre-eclampsia Br J Obstet Gynaecol 1996; 103: 603–607.
28. De Caterina R, Berini W, Libby P. Fatty acid structural requirements for the inhibition of endothelial activation [abstract]. Proceedings of the 69th Scientific Sessions of the American Heart Association 10–13 November 1996; New Orleans USA: 8.
29. Huang ZH, Bates EJ, Ferrante JV et al. Inhibition of stimulusinduced endothelial cell intercellular adhesion molecule-I, E-selectin, and vascular cell intercellular adhesion molecule-1 expression by arachidonic acid acid and its hydroxy and hydroperoxy derivatives. Circ Res 1997; 80: 149–158.
30. Chen LY, Lawson DL, Mehta JL. Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium derived relaxing factor. Thromh Res 1994; 76: 317–322.
31. Israel DH, Gorlin R. Fish oils in the prevention of atherosclerosis. J Am Coll Cardiol 1992; 19: 176–185.
32. Stuhlmeier KM, Tam C, Csizmadia V, Bach FH. Selective suppression of endothelial cell activation by arachadonic acid. Eur J Immunol 1996; 26: 1417–1423.
33. Crawford MA. The role of essential fatty acids in neural development: implications for perinatal nutrition. Am J Clin Nutr 1993; 57 (Suppl): 703s–710s.
34. Carlson SE, Cooke RJ, Werkman SH, Tolley EA. First year growth of preterm infants fed standard compared to marine oil supplemented formula. Lipids 1992; 27: 901–907.
35. Holman RT, Johnson SB, Ogburn PL. Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation. Proc Natl Acad Sci USA 1991; 88: 4835–4839.
36. AI MDM, Van Houwelingen AC, Kester ADM, Hasaart THM, De Jong AD, Hornstra G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr 1995; 74: 55–68.
37. Sattar N, Gaw A, Stephens IFD, Horrobin D, Glen ACA. Pregnancy associated changes in plasma and erythrocyte membrane essential fatty acids [abstract]. Proceedings of the 2nd International Society for the Study of Fatty Acids and Lipids (ISSFAL) 7–10 June 1995; Washington USA 53.
38. Reece EA, Wu Y-W, Wiznitzer A et al. Dietary polyunsaturated fatty acids prevents malformations in offspring of diabetic rats. Am J Obstet Gynecol 1996; 175: 818–823.
39. Pauletto P, Puato M, Caroll MG et al. Blood pressure and atherogenic lipoprotein profiles of fish diet and vegetarian villagers in Tanzania: the Lugalawa study. Lancet 1996; 348: 786–788.
40. Knapp HR, Fitzgerald GA. The antihypertensive effects of fish oil. N Engl J Med 1989; 320: 1037–1043.
41. Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. New Engl J Med 1995; 333: 1369–1373.
42. Tobin D. Fish oil supplementation in pregnancy. Lancet 1992; 340: 118.
43. Sorensen JD, Olsen SF, Secher NJ, Jepersen J. Effects of fish oil supplementation in late pregnancy on blood lipids, serum urate, coagulation and fibrinolysis. A randomised trial. Fibrinolysis 1994; 8: 54–60.
44. Chambez J, Ravel D, Manier M-C, Pepin D, Mulliez N, Bereziat G. Essential fatty acids interconversion in the human fetal liver. Biol Neonate 1985; 47: 136–140.
45. Crawford MA, Hassam AG, Williams G, Whitehouse WL. Essential fatty acids and fetal brain growth. Lancet 1976; 1: 452–453.
46. van Houwelingen AC, Sorenson JDJ, Hornstra G et al. Essential fatty acids in neonates after fish oil supplementation during late pregnancy. Br J Nutr 1995; 74: 723–731.
47. Connor WE, Lowensohn R, Hatcher L. Increased docosa-hexaenoic acid levels in human newborn infants by the administration of sardines and fish oil during pregnancy. Lipids 1996; 31: S183–s187.
48. Wainwright PE. Do essential fatty acids play a role in brain and behavioural development Neurosci Behav Rev 1992; 16: 193–205.
49. Neuringer M, Connor WE, Lin DS, Barstad L, Luck S. Biochemical and functional effects of prenatal and postnatal ω3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci USA 1986; 83: 4021–4025.
50. Foreman-van Drongelen MM, Ziejdner EE, van Houwelingen AC, Kester AD, Al MD, Hassart TH, Hornstra G. Essential fatty acid status measured in umbilical vessel walls of infants born after multiple pregnancy. Early Human Dev 1996; 46: 203–215.
51. Ziejdner EE, Van Houwelingen AC, Kester AD, Hornstra G. Essential fatty acid status in plasma phospholipids of mother and neonate after multiple pregnancy. Prostaglandins Leuko Essen.
52. Fatty Acids 1997; 56: 395–401.
53. Rawlings JS, Rawlings VB, Read JA. Prevalence of low birth weight and preterm delivery in relation to the interval between pregnancies among white and black women. N Engl J Med 1995; 332: 69–74.
54. Peterson DB, Fisher K, Carter RD, Mann J. Fatty acid composition of erythrocytes and plasma triglyceride and cardio vascular risk in Asian diabetic patients. Lancet 1994; 343: 1528–1530.
55. Reddy S, Sanders TA, Obeid O. The influence of maternal vegetarian diet on essential fatty acid status of the newborn. Eur J Clin Nutr 1994; 48: 358–368.
56. Crawford MA, Doyle W, Drury P, Lennon A, Costeloe K, Leighfield M. n-6 and n-3 fatty acids during early human development. J Int Med 1989; 225 (Suppl 1): 159–169.
57. Yeh YY, Gehman MF, Yeh SM. Maternal dietary fish oil enriches docosahexaenoate levels in brain subcellular fractions of off spring. J Neurosci Res 1993; 35: 218–226.
58. Jensen CL, Heird WC, Anderson RE. Docosahexaenoic acid supplementation of lactating women [abstract]. Proceedings of the International Conference of Highly Unsaturated Fatty Acids in Nutrition and Disease Prevention. November 1996; Barcelona, Spain: 61–62.
59. Makrides M. Defining essential fatty acid requirements in pregnancy and lactation [abstract]. Proceedings of the International Conference of Highly Unsaturated Fatty Acids in Nutrition and Disease Prevention. November 1996; Barcelona, Spain: 65.
60. Hoffman DR, Birch EE, Birch D, Uauy RD. Effects of supplementation with w3 long-chain polyunsaturated fatty acids on retinal and cortical development in premature infants Am J Clin Nutr 1993; 57 (Suppl): 807s–812s.
61. Morley R, Lucas A. Early diet and outcome in prematurely born children. Clin Nutr 1993; 12: S6–S11.
62. Carlson SE, Werkman SH, Peeples JM, Wilson WM. Long-chain fatty acids and early visual and cognitive development of pre-term infants. Eur J Clin Nutr 1994; 48: S: 27–30.
63. Agostini C, Riva E, Trojan S, Bellu R, Giovannini M. Docosahexaenoic acid status and developmental quotient of healthy term infants. Lancet 1995; 346 638.
64. Proceedings of the Conference on PUFA in Infant Nutrition [abstracts]: Consensus and Controversies. American Oil Chemists Society. November 1996; Barcelona, Spain: 34.
65. Devynck MA. Do cell membrane dynamics participate in insulin resistance. Lancet 1995; 345: 336.
66. Vessby B, Aro A, Skarfors E, Berglund L, Salminen I, Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 1994; 43: 1353–1357.
67. Baur LA, OConnor J, Pan DA, Kriketos AD, Storlein LH. The relationship between type of feeding, skeletal muscle membrane phospholipid fatty acid composition, and plasma glucose levels [abstract]. Proceedings of the Conference on PUFA in Infant Nutrition: Consensus and Controversies. American Oil Chemists Society. November 1996; Barcelona, Spain: 5–6.
68. Barker DJP. Fetal origins of coronary heart disease. BMJ 1995; 311: 171–174.